Is ENZC a penny stock?

(OTC: ENZC) Enzolytics Inc. is a biotech penny stock that is working on a variety of treatments for different ailments.

Similarly Is ENZC a pink stock? ( OTC PINK :ENZC) (https://enzolytics.

Performance Outlook.

Previous Close 0.0667
52 Week Range 0.0600 – 0.3195
Volume 6,234,511
Avg. Volume 7,558,321

How many shares does ENZC have? Share Statistics

Avg Vol (3 month) 3 7.55M
Shares Outstanding 5 2.44B
Implied Shares Outstanding 6 N/A
Float 8 N/A
% Held by Insiders 1 0.00%

Additionally, How do I invest in ENZC?

Shares of ENZC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What does ENZC company do?

Enzolytics Inc (OTC Pink – Current Information:ENZC)

Enzolytics, Inc. is a biotechnology company, which engages in the development and commercialization of drugs for infectious disease treatments.

Who sells ENZC stock? How do I buy shares of Enzolytics? Shares of ENZC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

Is ENZC an OTC stock? Stock Quote ( U.S.: OTC ) | MarketWatch.

Performance.

5 Day 1.10%
YTD 12.83%
1 Year -61.95%

Is ENZC on Nasdaq? Enzolytics Inc (ENZC) Stock Price, Quote, News & History | Nasdaq.

Is Enzolytics a real company?

Enzolytics, Inc. is a biotechnology company, which engages in the development and commercialization of drugs for infectious disease treatments.

What kind of company is ENZC? Enzolytics, Inc. is a drug development biotechnology company. The Company is engaged in the commercialization of its proteins for the treatment of debilitating infectious diseases. The Company is focused in developing monoclonal antibody therapy and treating infectious diseases.

Is Enzolytics a real company?

Enzolytics Inc. operates as a drug development company. The Company develops drugs for the treatment of debilitating infectious diseases. Enzolytics serves medical sector in the United States.

What is happening with Enzolytics? Enzolytics is currently moving forward to produce monoclonal antibodies targeting COVID-19.

 

Zeen is a next generation WordPress theme. It’s powerful, beautifully designed and comes with everything you need to engage your visitors and increase conversions.